MedTrace Logo

Breast, Omega 3 Free Fatty Acid, Ph 0

NCT02996240 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2021-03-17

No results posted yet for this study

Summary

Assess the impact of dietary omega 3 free fatty acids breast cancer patients.

Conditions

  • Breastcancer

Interventions

DIETARY_SUPPLEMENT

Omega-3 FFA

Omega-3 Free Fatty Acid will be given as a fish oil in a capsule.

Sponsors & Collaborators

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Virginia G Kaklamani, MD · Principal Investigator

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-12
Primary Completion
2019-09-27
Completion
2021-02-22

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02996240 on ClinicalTrials.gov